Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2020 | 1 |
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Multiple doses of cell therapy and neurorehabilitation in amyotrophic lateral sclerosis: A case report.
Clin Pract. 2020 Sep 28;10(3):1242. doi: 10.4081/cp.2020.1242. eCollection 2020 Sep 4.
Clin Pract. 2020.
PMID: 33072247
Free PMC article.
The Regulatory Machinery of Neurodegeneration in In Vitro Models of Amyotrophic Lateral Sclerosis.
Ikiz B, Alvarez MJ, Ré DB, Le Verche V, Politi K, Lotti F, Phani S, Pradhan R, Yu C, Croft GF, Jacquier A, Henderson CE, Califano A, Przedborski S.
Ikiz B, et al. Among authors: pradhan r.
Cell Rep. 2015 Jul 14;12(2):335-45. doi: 10.1016/j.celrep.2015.06.019. Epub 2015 Jul 2.
Cell Rep. 2015.
PMID: 26146077
Free PMC article.
Item in Clipboard
A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial.
Sharma A, Shah M, Lakshmi S, Sane H, Captain J, Gokulchandran N, Khubchandani P, Pradeep MK, Gote P, Tuppekar B, Kulkarni P, Paranjape A, Pradhan R, Varghese R, Kasekar S, Nair V, Khanbande U.
Sharma A, et al. Among authors: pradhan r.
Int Immunopharmacol. 2021 Jul;96:107743. doi: 10.1016/j.intimp.2021.107743. Epub 2021 Apr 30.
Int Immunopharmacol. 2021.
PMID: 33984718
Free PMC article.
Clinical Trial.
Item in Clipboard
Corrigendum to "A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial" [Int. Immunopharmacol. 96 (2021) 107743].
Sharma A, Shah M, Lakshmi S, Sane H, Captain J, Gokulchandran N, Khubchandani P, Pradeep MK, Gote P, Tuppekar B, Kulkarni P, Paranjape A, Pradhan R, Varghese R, Kasekar S, Nair V, Khanbande U.
Sharma A, et al. Among authors: pradhan r.
Int Immunopharmacol. 2022 Jan;102:107932. doi: 10.1016/j.intimp.2021.107932. Epub 2021 Jul 15.
Int Immunopharmacol. 2022.
PMID: 34274220
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite